Erlotinib Terminated Phase 2 Trials for Adult Brain Tumors Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00387894Erlotinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma